Gilead Sciences names Lilly senior VP Christi L. Shaw as Kite CEO

pharmanewsdaily- July 12, 2019 0

US biopharma company Gilead Sciences has named Christi L. Shaw as the new chief executive officer of its subsidiary Kite, a California-based cell therapy company, ... Read More